Pharmafile Logo

Internal Brand Planning Sessions on the Impetus InSite Platform®

A Customer Story

In this Customer Story, we share how a nephrology brand team approached Impetus Digital for help with streamlining and optimizing their annual brand planning and strategic discussions. In the early parts of the pandemic, they had attempted to host these meetings themselves over a standard web meeting platform. While they understood the benefits of virtual, they found it difficult to align and reach consensus through their current approach due to a lack of an integrated view of all moving parts and diverse viewpoints.

After meeting with Impetus’ team of strategic experts, the client opted for a hybrid of asynchronous (over-time, anytime) and synchronous (real-time) virtual meetings and interactive tools to meet all strategic objectives in an as efficient as possible manner.

Broadly, the client’s main objectives were to:

  1. Simplify the typically rigid annual brand planning process, shorten decision-making times, and optimize global/local alignment and collaboration.
  2. Conduct a deep-dive business review, including of brand positioning, and identify key drivers and barriers for the brand in the year to come.
  3. Clearly articulate strategic priorities, operational goals, and implementation tactics, then attain approval/endorsement from the executive team to launch the strategic plan.
  4. Create a detailed and actionable brand plan, allocating the brand’s limited resources to the initiatives that will result in the highest return on investment.

To learn more about our client’s approach and the outcomes of this project, access the full customer story here.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...

Navigating the Nuances of Europe’s MedTech Industry

Richard Houlihan, CEO of EirMed, explores topics related to EUDAMED, the European Databank for Medical Devices, including the key pain points and concerns MedTech companies encounter related to EUDAMED and...

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with...

Traversing the Medtech Regulatory Landscape in the Interest of Patients

Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting...

Scanning for Health Indicators and Risks Through Your Smartphone

Vlado Bosanac, Co-Founder & Head of Strategy and Revenue Growth at Advanced Human Imaging, dives into the implications of increased integration of tech and data into daily life for the...

Virtual MSL/Sales training programs and events

Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events

Top 10 Benefits of Virtual Advisory Boards

As the world is slowly starting to open up again, it can be tempting to rush back to the pre-pandemic days of in-person advisory boards. However, it would be foolish...

Amplifying Opinions of Patients & Caregivers for Higher Quality of Care

Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey...

The Future of MedTech: Streamlined Clinical Data Collection & Management

JĂłn Ingi Bergsteinsson, Co-founder & CCO at SMART-TRIAL, explores the barriers to, and benefits of, digitalization of clinical operations and trials in the MedTech industry, plus much more!

Digital Opinion Leaders (DOLs): Who are they and how can Pharma engage them?

With our growing dependence on social media, Digital Opinion Leaders are becoming an increasingly important stakeholder group for Pharma teams to engage and consult. But who are these DOLs, and...